Table of Contents
NEW YORK — According to a report by MSN, Walgreens Boots stock rose 6% at least partly amid a report about financing for a potential buyout of the drugstore chain by Sycamore Partners.
The report said private equity firm Sycamore Partners is working with Morgan Stanley and UBS on a $10 billion finacing package for a potential acquistion of Walgreens (WBA, according to a posting on X from Octus, the publication formerly known as Reorg.
A potential buyout would include terms loans, a bridge loan, and asset-based lending, according to the post.
The latest reporting comes after CNBC's David Faber last Tuesday said there are still signs of life in Sycamore's takeover talks with the pharmacy chain, sending Walgreens shares soaring 14%.
The update also comes after Bloomberg reported late last month that Sycamore is talking to private equity confirms about debt financing for a potential takeover.
In other company news, WBA has agreed to pay $595 million to settle a contract dispute with telemedicine provider Everly Health Solutions. The settlement, announced on February 25, 2025, ends a lengthy legal battle over COVID-19 testing. Walgreens will pay the amount within two business days, closing all claims without admitting any wrongdoing.
